A bootstrappers podcast for founders, entrepreneurs, visionaries and dreamers who are building businesses from the ground up without the taking on debt or selling equity. Here we cover marketing, sales, organization and mindset issues that matter to you
…
continue reading
Content provided by Business in 60 Seconds and TRT World. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Business in 60 Seconds and TRT World or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
March 18, 2021 Biz in 60
MP3•Episode home
Manage episode 287792111 series 1419069
Content provided by Business in 60 Seconds and TRT World. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Business in 60 Seconds and TRT World or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
New Zealand's economy unexpectedly shrinks 1% in Q4 New Zealand's economy suffered a surprise contraction in the fourth quarter, denting hopes of a swift recovery from the pandemic. GDP shrank by 1 percent in the final three months of 2020, following nearly 14 percent growth in the third quarter. Economists expect the economy to shrink further in the current quarter, which would put the Pacific nation in a technical recession. Credit Suisse suspends bonuses over Greensill collapse Credit Suisse will overhaul its asset management business and suspend bonuses for some senior executives as it tries to contain the fallout from the collapse of Greensill Capital. The Swiss lender had multiple ties to Greensill, including 10-billion dollars of funds that offered exposure to the company's loans and were marketed to the bank's clients as safe investments. Shares in SK Bioscience jump 160% on market debut Shares in South Korean vaccine maker, SK Bioscience, more than doubled on their market debut. The company's stock jumped 160 percent on Seoul's KOSPI exchange, boosting its market value to 11-and- a-half billion dollars. The local manufacturer of AstraZeneca's vaccine raised 1-point-3 billion dollars from the IPO, marking the biggest domestic listing since 2017.
…
continue reading
173 episodes
MP3•Episode home
Manage episode 287792111 series 1419069
Content provided by Business in 60 Seconds and TRT World. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Business in 60 Seconds and TRT World or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
New Zealand's economy unexpectedly shrinks 1% in Q4 New Zealand's economy suffered a surprise contraction in the fourth quarter, denting hopes of a swift recovery from the pandemic. GDP shrank by 1 percent in the final three months of 2020, following nearly 14 percent growth in the third quarter. Economists expect the economy to shrink further in the current quarter, which would put the Pacific nation in a technical recession. Credit Suisse suspends bonuses over Greensill collapse Credit Suisse will overhaul its asset management business and suspend bonuses for some senior executives as it tries to contain the fallout from the collapse of Greensill Capital. The Swiss lender had multiple ties to Greensill, including 10-billion dollars of funds that offered exposure to the company's loans and were marketed to the bank's clients as safe investments. Shares in SK Bioscience jump 160% on market debut Shares in South Korean vaccine maker, SK Bioscience, more than doubled on their market debut. The company's stock jumped 160 percent on Seoul's KOSPI exchange, boosting its market value to 11-and- a-half billion dollars. The local manufacturer of AstraZeneca's vaccine raised 1-point-3 billion dollars from the IPO, marking the biggest domestic listing since 2017.
…
continue reading
173 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.